Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Neurocrine Biosciences Inc | NBIX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 141.65 | 03:18:40 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 141.65 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 89.04 - 148.3699 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 141.65 | USD |
Neurocrine Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 14.1B | 99.51M | - | 1.89B | 249.7M | 2.51 | 56.45 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Neurocrine Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NBIX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 137.12 | 143.05 | 134.79 | 141.27 | 627,138 | 4.53 | 3.30% |
| 1 Month | 141.00 | 145.22 | 134.79 | 139.86 | 778,070 | 0.65 | 0.46% |
| 3 Months | 135.12 | 148.3699 | 129.15 | 138.02 | 851,977 | 6.53 | 4.83% |
| 6 Months | 109.89 | 148.3699 | 108.63 | 133.72 | 821,408 | 31.76 | 28.90% |
| 1 Year | 94.27 | 148.3699 | 89.04 | 119.86 | 767,207 | 47.38 | 50.26% |
| 3 Years | 95.13 | 148.3699 | 71.875 | 105.18 | 762,287 | 46.52 | 48.90% |
| 5 Years | 77.55 | 148.3699 | 71.875 | 103.87 | 795,286 | 64.10 | 82.66% |
Neurocrine Biosciences Description
| Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome. |
